Richard Forth

589 citations

24 papers · 447 indexed · h-index 11

Impact in

Physiology top 5%
- Asthma and respiratory diseases
Pulmonary and Respiratory Medicine top 5%
- Inhalation and Respiratory Drug Delivery
- Respiratory and Cough-Related Research
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Respiratory Support and Mechanisms

Papers in ⓘ

Physiology 23
- Asthma and respiratory diseases 22
Pulmonary and Respiratory Medicine 18
- Respiratory and Cough-Related Research 15
- Inhalation and Respiratory Drug Delivery 11
- Chronic Obstructive Pulmonary Disease (COPD) Research 4

Co-authors: Loretta Jacques (18 shared papers)Eric D. Bateman (14 shared papers)Ashley Woodcock (14 shared papers)Jan Lötvall (13 shared papers)Eugene R. Bleecker (11 shared papers)Paul M. O’Byrne (10 shared papers)Brett Haumann (4 shared papers)Angela Davis (2 shared papers)
Journals: Journal of Asthma (4 papers)Respiratory Medicine (2 papers)Respiratory Research (2 papers)The Journal of Allergy and Clinical Immunology In Practice (2 papers)Allergy (1 paper)
Partner nations: United Kingdom United States South Africa

In The Last Decade

Richard Forth

24 papers receiving 441 citations

Peers

Countries citing papers authored by Richard Forth

Since Specialization

Citations

This map shows the geographic impact of Richard Forth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Forth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Forth more than expected).

Fields of papers citing papers by Richard Forth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Forth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Forth. The network helps show where Richard Forth may publish in the future.

Co-authors

The 25 scholars most cited alongside Richard Forth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Richard Forth Line = papers co-authored together Richard Forth links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial Thorax ·William W. Busse, Eugene R. Bleecker, Eric D. Bateman, Jan Lötvall, Richard Forth, Angela Davis, Loretta Jacques, Brett Haumann, Ashley Woodcock	2011	67
2	Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma European Respiratory Journal ·Paul M. O’Byrne, Eugene R. Bleecker, Eric D. Bateman, (unknown), Ashley Woodcock, Richard Forth, William T. Toler, Loretta Jacques, Jan Lötvall	2013	65
3	Dose effect of once-daily fluticasone furoate in persistent asthma: A randomized trial Respiratory Medicine ·Eric D. Bateman, Eugene R. Bleecker, Jan Lötvall, Ashley Woodcock, Richard Forth, Hilary Medley, Angela Davis, Loretta Jacques, Brett Haumann, (unknown)	2012	57
4	Fluticasone Furoate–Vilanterol 100-25 mcg Compared with Fluticasone Furoate 100 mcg in Asthma: A Randomized Trial The Journal of Allergy and Clinical Immunology In Practice ·Eugene R. Bleecker, Jan Lötvall, Paul M. O’Byrne, Ashley Woodcock, (unknown), Edward Kerwin, Richard Forth, Hilary Medley, Carol Nunn, Loretta Jacques, Eric D. Bateman	2014	39
5	Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial Respiratory Research ·Ashley Woodcock, Eric D. Bateman, (unknown), Jan Lötvall, Neil G. Snowise, Richard Forth, Loretta Jacques, Brett Haumann, Eugene R. Bleecker	2011	38
6	Fluticasone furoate (FF)/vilanterol (100/25 mcg or 200/25 mcg) or FF (100 mcg) in persistent asthma Journal of Asthma ·David I. Bernstein, Eric D. Bateman, Ashley Woodcock, William T. Toler, Richard Forth, Loretta Jacques, Carol Nunn, Paul M. O’Byrne	2015	37
7	Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: A 24-week placebo and active-controlled randomised trial Respiratory Medicine ·Jan Lötvall, Eugene R. Bleecker, (unknown), Paul M. O’Byrne, Ashley Woodcock, Edward Kerwin, Sally Stone, Richard Forth, Loretta Jacques, Eric D. Bateman	2013	31
8	Urine output on an intensive care unit: case-control study BMJ ·Anthony W. Solomon, Christopher J. Kirwan, Neâl Alexander, Kofi Nimako, A. Jurukov, Richard Forth, T. Rahman, (unknown)	2010	26
9	Once‐daily fluticasone furoate 50 mcg in mild‐to‐moderate asthma: a 24‐week placebo‐controlled randomized trial Allergy ·(unknown), Eric D. Bateman, Paul M. O’Byrne, Jan Lötvall, Ashley Woodcock, Hilary Medley, Richard Forth, Loretta Jacques	2014	20
10	Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial Respiratory Research ·Paul M. O’Byrne, Ashley Woodcock, Eugene R. Bleecker, Eric D. Bateman, Jan Lötvall, Richard Forth, Hilary Medley, Loretta Jacques, (unknown)	2014	19
11	Once-daily fluticasone furoate/vilanterol versus twice-daily fluticasone propionate/salmeterol in patients with asthma well controlled on ICS/LABA Journal of Asthma ·David I. Bernstein, Leslie Andersen, Richard Forth, Loretta Jacques, Louisa Yates	2017	11
12	Efficacy of fluticasone furoate (FF) as a monotherapy and in combination with vilanterol (VI) over 12 weeks in patients with persistent asthma Eugene R. Bleecker, Jan Lötvall, Paul M. O'Bryne, Ashley Woodcock, William W. Busse, Richard Forth, Hilary Medley, Carol Nunn, Loretta Jacques, Eric D. Bateman	2012	8
13	Insights from the AUSTRI study on reliever use before and after asthma exacerbations The Journal of Allergy and Clinical Immunology In Practice ·William W. Busse, David A. Stempel, Bhumika Aggarwal, Isabelle Boucot, Richard Forth, Ibrahim Raphiou, Klaus F. Rabe, Helen K. Reddel	2022	7
14	Efficacy and safety of fluticasone furoate (FF)/vilanterol (VI) once daily (OD) for 24 weeks in persistent asthma Paul M. O’Byrne, Eugene R. Bleecker, Eric D. Bateman, William W. Busse, Ashley Woodcock, Richard Forth, T. Toler, Loretta Jacques, Jan Lötvall	2012	6
15	Fluticasone furoate/vilanterol versus fluticasone propionate in patients with asthma and exercise-induced bronchoconstriction Journal of Asthma ·Neil Martin, John M. Weiler, David S. Pearlman, Loretta Jacques, Carol Nunn, Richard Forth, Sarah West, Karen S. Dunn, Paul M. O’Byrne	2019	4
16	Efficacy and safety of once-daily (OD) fluticasone furoate (FF) in patients with persistent asthma: A 24-week randomised trial Jan Lötvall, Eugene R. Bleecker, William W. Busse, Paul M. O’Byrne, Ashley Woodcock, Eric D. Bateman, Edward Kerwin, Sally Stone, Richard Forth, Loretta Jacques	2012	2
17	Comparison of Once Daily Fluticasone Furoate/Vilanterol With Twice Daily Fluticasone Propionate/Salmeterol in Patients With Controlled Asthma CHEST Journal ·David I. Bernstein, Richard Forth, Louisa Yates, Leslie Andersen, Loretta Jacques	2017	2
18	Fluticasone Furoate (FF), A Once-Daily Inhaled Corticosteroid (ICS), Is Efficacious In Patients With Uncontrolled Asthma Across A Range Of Treatment Steps William W. Busse, Eric D. Bateman, Eugene R. Bleecker, Jan Lötvall, Ashley Woodcock, Richard Forth, Loretta Jacques, Hilary Medley, Brett Haumann	2011	2
19	Once-daily fluticasone furoate/vilanterol vs once-daily fluticasone furoate in patients with asthma aged 5 to 17 years Annals of Allergy Asthma & Immunology ·Philippe Bareille, Richard Forth, Varsha Imber, Irina Bondarenko, Arthur Michaud, Bernadetta Majorek-Olechowska	2024	1
20	Fluticasone furoate/vilanterol once daily improves night-time awakenings in asthma patients with night symptoms: Post hoc analyses of three randomized controlled trials Journal of Asthma ·Edward Kerwin, Neil Barnes, M.R.J. Gibbs, David Leather, Richard Forth, Loretta Jacques, Louisa Yates	2017	1

About Richard Forth

Richard Forth is a scholar working on Physiology, Pulmonary and Respiratory Medicine, Animal Science and Zoology, Immunology and Allergy and Surgery, having authored 24 papers that have together received 447 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (22 papers), Respiratory and Cough-Related Research (15 papers), Inhalation and Respiratory Drug Delivery (11 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Pharmacological Effects and Assays (3 papers), Allergic Rhinitis and Sensitization (2 papers), Cardiac, Anesthesia and Surgical Outcomes (1 paper) and Hemodynamic Monitoring and Therapy (1 paper). The work is most often cited by research in Physiology (411 citations), Pulmonary and Respiratory Medicine (395 citations), Immunology and Allergy (18 citations), Animal Science and Zoology (23 citations) and Nephrology (13 citations). Richard Forth has collaborated with scholars based in United Kingdom, United States and South Africa. Frequent co-authors include Loretta Jacques, Eric D. Bateman, Ashley Woodcock, Jan Lötvall, Eugene R. Bleecker, Paul M. O’Byrne, Brett Haumann, Angela Davis, William W. Busse and David I. Bernstein. Their work appears in journals such as Journal of Asthma, Respiratory Medicine, Respiratory Research, The Journal of Allergy and Clinical Immunology In Practice and Allergy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact